Articular cartilage regeneration by activated skeletal stem cells.
Level 5 - mechanism / opinion, no new human data
Preclinical animal and laboratory tissue study
PubMed 32807933 · doi:10.1038/s41591-020-1013-2
What was done
The authors investigated resident skeletal stem cell populations across age in human and mouse joints. In adult mice, they tested whether microfracture surgery could trigger local stem cell expansion in joint chondral surfaces, and whether localized hydrogel co-delivery of bone morphogenetic protein 2 (BMP2) and soluble vascular endothelial growth factor receptor 1 (sVEGFR1) could guide stem cell differentiation toward articular cartilage.
What was found
The abstract reports no quantitative values or statistical metrics. Aging was associated with progressive loss of skeletal stem cells and diminished chondrogenesis in mice and humans. Microfracture surgery triggered local expansion of skeletal stem cells in adult mouse joints, which spontaneously formed fibrous tissue; co-delivery of BMP2 and sVEGFR1 redirected these cells to differentiate into articular cartilage.
Why it matters
This study provides preclinical evidence that combining microfracture surgery with targeted signaling factors can steer resident stem cells toward articular cartilage regeneration instead of fibrous scar tissue.
Limits
The therapeutic intervention was tested in mice, not humans. The abstract does not provide sample sizes, effect sizes, statistical measures, or long-term functional and biomechanical outcomes of the regenerated tissue.